Harnessing ecology to deliver
novel, cultured microbial therapies​

Introducing BiomeBank
BiomeBank is a clinical-stage biotechnology company that aims to treat and prevent disease by restoring gut microbial ecology.
(1:40)

What is the Consortiome Technology?

Our team of translational microbiome experts have developed a breakthrough co-culturing platform that has enabled us to generate an artificial human gut microbial community in a bioreactor – the Consortiome™.

(2:00)

Investor Presentation 

Learn more about how BiomeBank plans to become a global leader in the discovery and commercialisation of microbial therapies.

(6:40)